INTERVENTIONAL CARDIOLOGY: VASCULAR ACCESS SITE CLOSURE PRODUCTS | GLOBAL MARKETS

88 Pages | 48 Exhibits | 2018 Analysis | Forecasts Through 2022 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for vascular access site closure products.

CARDIOLOGY MARKET HIGHLIGHTS

  • Total unit sales for vascular access site closure products are moderately increasing due to a number of factors, including: the increasing prevalence of CVD, advances in CVD diagnostics, and demand for minimally invasive interventional therapies to treat patients requiring surgical interventions to manage their conditions.
  • In 2017, vascular closure devices, which includes active and passive approximators, accounted for the majority of total vascular access site closure product sales.
  • The global market for vascular access site closure products is anticipated to increase at a CAGR of 6.5% during the forecast period (2017-22), reaching approximately $1,023.8m in total product sales by 2022.
  • The US was the largest market for vascular access site closure product sales, and was estimated to account for approximately 40% of all product sales in 2017. Meddevicetracker estimates that the rest of the world (RoW) segment will see the strongest growth throughout the forecast period.
  • The majority of vascular access site closure product sales are attributable to three of the largest competitors in the market: Abbott, Cardinal Health, and Terumo Interventional Systems.
TOPICS COVERED INCLUDE:
  • An overview of vascular access site closure products used to achieve hemostasis at the access site of cardiovascular catheterization procedures.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses.
  • Discussion of key drivers and limiters impacting the vascular access site closure products market.
  • Primary research with interventional cardiologists from the US, five major EU markets, and Japan focused on how physicians are utilizing these devices and their preferred/most frequently utilized manufacturers.
  • A review of emerging technologies which could impact sales of existing devices.


TABLE OF CONTENTS:
Executive Summary

i. Cardiovascular diseases overview
ii. Global vascular access site closure products market
	a. Market drivers and limiters
	b. Device segment insights
	c. Technology trends
	d. Market leaders
	e. Competitive strategies
	f. Emerging competition 
iii. Methodology

Exhibit ES-1: Vascular access site closure products, global market forecast, 2017-22 
Exhibit ES-2: Global vascular access site closure products market, share by country/region, 2017 
Exhibit ES-3: Drivers and limiters of growth - vascular access site closure products 

1. Cardiovascular Diseases Overview
 
1.1 Acute coronary syndrome
	1.1.1 Atherosclerosis 
	1.1.2 Angina pectoris
	1.1.3 Myocardial infarction
	1.1.4 Diagnosis and treatment
1.2 Hypertension
1.3 Heart failure 
1.4 Peripheral vascular disease
	1.4.1 Critical limb ischemia 
	1.4.2 Aneurysm
	1.4.3 Deep vein thrombosis/pulmonary embolism
	1.4.4 Diagnosis and treatment
1.5 Cerebrovascular disease 
	1.5.1 Diagnosis and treatment
1.6 Bibliography 

Exhibit 1-1: Estimated deaths attributable to cardiovascular disease, select countries, 2016 
Exhibit 1-2: Top 10 countries with the highest CVD death rates for males and females
Exhibit 1-3: Estimated incident cases for acute coronary syndrome, select continents, 2017
Exhibit 1-4: Estimated deaths attributable to ischemic heart disease, select countries, 2016
Exhibit 1-5: Age-standardized incidence (per 100,000) of angina pectoris, select regions, 1990 and 2010
Exhibit 1-6: Clinical classification of acute myocardial infarction
Exhibit 1-7: Age-standardized incidence (per 100,000) of acute myocardial infarction, select regions, 1990 and 2010
Exhibit 1-8: Estimated prevalent cases of hypertension, select countries, 2017 
Exhibit 1-9: Estimated deaths attributable to hypertensive heart disease, select countries, 2016 
Exhibit 1-10: Estimated incidence of acute decompensated heart failure, select countries, 2017 
Exhibit 1-11: Estimated prevalent cases of chronic heart failure, select countries, 2017
Exhibit 1-12: Estimated prevalence of peripheral artery disease, select countries, 2016 
Exhibit 1-13: Estimated incident cases of DVT, select countries, 2017 
Exhibit 1-14: Estimated incident cases of PE, select countries, 2017
Exhibit 1-15: Estimated incident cases of ischemic stroke, select countries, 2017
Exhibit 1-16: Estimated incident cases of hemorrhagic stroke, select countries, 2017 
Exhibit 1-17: Estimated prevalent cases of ischemic stroke, select countries, 2017 
Exhibit 1-18: Estimated prevalent cases of hemorrhagic stroke, select countries, 2017

2. Vascular Access Site Closure Products

2.1 Types of vascular closure products
	2.1.1 Advantages and disadvantages
2.2 Vascular closure devices
2.3 Hemostatic compressive devices
2.4 Other hemostatic products
2.5 Bibliography 

Exhibit 2-1: Advantages and disadvantages of vascular closure devices
Exhibit 2-2: Selected vascular closure devices
Exhibit 2-3: Selected hemostatic compressive devices 
Exhibit 2-4: Selected hemostatic products for the management of vascular access sites

3. Vascular Access Site Closure Products Market

3.1 Global market insights
	3.1.1 Market value
	3.1.2 Technology trends 
	3.1.3 Market drivers and limiters 
	3.1.4 Vascular access site closure products overview 
	3.1.5 Market leaders
	3.1.6 Competitive strategies
	3.1.7 Emerging competition 
3.2 Global competitors 
3.3 Market forecast
	3.3.1 Market forecast: US 
	3.3.2 Market forecast: five major EU markets
	3.3.3 Market forecast: Japan 
	3.3.4 Market forecast: Rest of the world
3.4 Primary research
3.5 Bibliography 

Exhibit 3-1: Vascular access site closure products, global market forecast, 2017-22 
Exhibit 3-2: Global vascular access site closure products market, share by country/region, 2017
Exhibit 3-3: Global vascular access site closure product sales, combined market forecast ($m), by country/region, 2017-22
Exhibit 3-4: Drivers and limiters of market growth - vascular access site closure products
Exhibit 3-5: Vascular access site closure products, share by product type, for 2017 and 2022
Exhibit 3-6: Global vascular access site closure products market, share by supplier, 2017
Exhibit 3-7: US minimally invasive interventional cardiology, procedure volumes forecast (000s), 2017-22
Exhibit 3-8: US vascular access site closure products, estimated procedure volumes forecast (000s), 2017-22
Exhibit 3-9: US vascular access site closure product sales, estimated market forecast ($m), 2017-22
Exhibit 3-10: US vascular access site closure products market, share by supplier, 2017
Exhibit 3-11: 5EU minimally invasive interventional cardiology, procedure volumes forecast (000s), 2017-22
Exhibit 3-12: 5EU vascular access site closure products, estimated procedure volumes forecast (000s), 2017-22
Exhibit 3-13: 5EU vascular access site closure product sales, estimated market forecast ($m), 2017-22 
Exhibit 3-14: 5EU vascular access site closure products market, share by supplier, 2017
Exhibit 3-15: Japanese minimally invasive interventional cardiology, procedure volumes forecast (000s), 2017-22
Exhibit 3-16: Japanese vascular access site closure products, estimated procedure volumes forecast (000s), 2017-22
Exhibit 3-17: Japanese vascular access site closure product sales, estimated market forecast ($m), 2017-22
Exhibit 3-18: Japanese vascular access site closure products market, share by supplier, 2017 
Exhibit 3-19: RoW vascular access site closure product sales, estimated market forecast ($m), 2017-22 
Exhibit 3-20: RoW vascular access site closure products market, share by supplier, 2017 
Exhibit 3-21: Reported average number of interventional cardiology procedures performed monthly - survey results
Exhibit 3-22: Reported average utilization of vascular access site closure products, by region - survey results
Exhibit 3-23: Reported average utilization of vascular access sites, by region - survey results

Appendix: Company Listing


COMPANIES COVERED:

  1. Abbott
  2. Advanced Vascular Dynamics/Semler Technologies
  3. Cardiva Medical
  4. Cardinal Health
  5. CryoLife
  6. Essential Medical/Teleflex
  7. Edwards Lifesciences
  8. InSeal Medical
  9. Marine Polymer Technologies
  10. Medtronic
  11. Merit Medical Systems
  12. Morris Innovative
  13. Rex Medical
  14. Teleflex
  15. Terumo Interventional Systems
  16. Transluminal Technologies
  17. Tricol Biomedical/Weifang Tricol Trading Co.
  18. TZ Medical
  19. Vasorum
  20. Vivasure Medical
  21. W.L. Gore & Associates
  22. Z-Medica
Contact Us

Need help finding medtech research? Let us help you!